IBRX News and Press, ImmunityBio Inc. From 10/24/23

2023-10-24 14:38:06 ET Summary ImmunityBio, Inc.'s drug Anktiva received a Complete Response Letter, or CRL, from the FDA, delaying its approval for the treatment of NMIBC. The CRL was related to deficiencies in the FDA's inspection of the company's third-party contract manufactur...

2023-10-24 12:25:10 ET More on ImmunityBio ImmunityBio: Ongoing Dilution And Regulatory Uncertainties Blur Investment Prospects ImmunityBio announces $470M equity and debt financing from founder Patrick Soon-Shiong and Nant Entities Seeking Alpha’s Quant Ratin...

2023-10-24 10:01:59 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in For further details see: American Well Corporation, ImmunityBio amon...

2023-10-23 10:00:15 ET Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector as earnings close in For further details see: ImmunityBio, Palatin Technologies among healthcare movers

Provides updated data on prolonged duration of complete response in BCG-Unresponsive and BCG-Naïve NMIBC patients Following the Type A Meeting with the FDA, ImmunityBio has completed the BLA resubmission addressing the issues in the Complete Response Letter. As part of this resub...

SAN DIEGO, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of ImmunityBio, Inc. (NASDAQ: IBRX). Investors, who purchased ImmunityBio, Inc. (NASDAQ: IBRX) shares prior to May 2022 and continue to hold any o...

2023-09-27 08:30:53 ET MillerKnoll  ( MLKN ) +17% rides 18% higher, sees improving organic orders during FQ1. Gaucho Group Holdings  ( VINO ) +15% . Ginkgo Bioworks Holdings  ( DNA ) +16% Announces Multi-Target RNA Discovery Collaboration w...

2023-09-15 15:27:31 ET The Allure of Short Squeeze Penny Stocks: High Risk, High Reward Trading Penny stocks, typically defined as stocks trading under $5 per share, offer traders massive upside profit potential but also higher risk due to greater volatility. When penny stocks becom...

2023-09-15 12:52:24 ET Shares of ImmunityBio (NASDAQ: IBRX) were up more than 30% for the week as of 10 a.m. ET on Friday, according to data provided by S&P Global Market Intelligence . The clinical-stage biotech 's stock closed at $1.29 last week and then rose to as hig...

2023-09-11 06:26:56 ET ImmunityBio ( NASDAQ: IBRX ) Monday said it has executed financing transactions resulting in about $200 million of proceeds to the company. The transaction includes an exchange into equity of current debt and a new convertible debt instrument from Nant C...